A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis

Acta Neurologica Scandinavica
F AshtariM Akbari

Abstract

To assess the efficacy and safety of low-dose topiramate in migraine prophylaxis vs propranolol. A randomized, double-blind, clinical trial including 62 patients with frequent migraine headaches (> or = 3 attacks per month) was performed for a period of 8 weeks. The patients were randomly divided into two treatment groups - treated by topiramate 50 mg/day and propranolol 80 mg/day, respectively. The patients were assessed at 0, 4, and 8 weeks of the study. Results - The topiramate group showed a reduction in the mean (+/-SD) of monthly migraine frequency from 6.07 (+/-1.89) to 1.83 (+/-1.39) episodes per month, headache intensity from 7.1 (+/-1.45) to 3.67 (+/-2.1) based on the Visual Analog Scale, and headache duration from 16.37 (+/-7.26) to 6.23 (+/-5.22) hours (P < 0.001). In the patients treated with propranolol, the mean (+/-SD) of monthly headache frequency declined from 5.83 (+/-1.98) to 2.2 (+/-1.67) per month, headache intensity lessened from 6.43 (+/-1.6) to 4.13 (+/-1.94) and headache duration decreased from 15.10 (+/-6.84) to 7.27 (+/-6.46) h (P < 0.001). This study demonstrated that both low-dose topiramate and propranolol could significantly reduce migraine headache frequency, intensity, and duration. However, co...Continue Reading

References

Apr 26, 2001·Der Nervenarzt·H J HuppertzA Schulze-Bonhage
Nov 25, 2003·Headache·Héctor R MartínezCarlos D Castillo
Apr 21, 2004·Archives of Neurology·Stephen D SilbersteinUNKNOWN MIGR-001 Study Group
Apr 19, 2005·Headache·Jan Lewis Brandes
Jun 1, 2005·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·D D'AmicoG Bussone
Jul 5, 2005·Der Internist·H-C Diener, V Limmroth
Apr 22, 2006·Seminars in Neurology·Thomas M Buchanan, Nabih M Ramadan
May 12, 2006·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·G BussoneD D'Amico
Sep 27, 2006·CNS Drugs·Mirja L Hämäläinen
Jan 11, 2007·Acta Neurologica Scandinavica·J PascualR Leira
Jan 31, 2007·Neurology·R B LiptonUNKNOWN AMPP Advisory Group
Feb 16, 2007·Headache·Stephen D SilbersteinUNKNOWN Topiramate Chronic Migraine Study Group
Apr 21, 2007·Headache·Ho Lun LiKwok Kwong Lau

❮ Previous
Next ❯

Citations

Oct 12, 2012·Current Treatment Options in Neurology·Linda A Hershey, Edward M Bednarczyk
Mar 2, 2012·Neurology·S D SilbersteinUNKNOWN Chronic Migraine Treatment Trial Research Group
Apr 25, 2012·Neurology·S D SilbersteinUNKNOWN Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
Jun 12, 2012·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Tamara PringsheimUNKNOWN Canadian Headache Society Prophylactic Guidelines Development Group
Feb 16, 2013·Indian Journal of Pediatrics·Razieh FallahAli Shamszadeh
Sep 29, 2011·The International Journal of Neuroscience·Dariush AfshariMansour Rezaei
Jan 12, 2012·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Ning LuoYannan Fang
Jun 19, 2014·Expert Opinion on Pharmacotherapy·Lorenza ChiossiPaolo Martelletti
Jul 16, 2011·Expert Opinion on Drug Metabolism & Toxicology·Anna FerrariEmilio Sternieri
Feb 14, 2015·Expert Opinion on Drug Safety·László VécseiJános Tajti
May 29, 2012·Pediatric Neurology·Tal Eidlitz-MarkusAvraham Zeharia
Oct 27, 2009·Neurologic Clinics·Linda J Stephen, Martin J Brodie
Mar 5, 2016·Headache·Francesca Bagnato, Janine Good
Oct 2, 2009·The Journal of Headache and Pain·Lars Jacob StovnerKnut Hagen
Feb 10, 2010·The Journal of Headache and Pain·Y L LoH C Siow
Oct 12, 2010·The Journal of Headache and Pain·Anders Hougaard, Peer Tfelt-Hansen
Apr 27, 2010·CNS Neuroscience & Therapeutics·Rhandi SenaratneMark Bennett
Apr 29, 2016·Headache·Scott D SpritzerJoseph F Drazkowski
Apr 27, 2010·Lancet·Lars Edvinsson, Mattias Linde
Apr 6, 2017·Cephalalgia : an International Journal of Headache·Jennifer Y XieFrank Porreca
Aug 15, 2014·Cephalalgia : an International Journal of Headache·Wim M MullenersMattias Linde
Nov 11, 2015·Cephalalgia : an International Journal of Headache·Anders Hougaard, Peer Tfelt-Hansen
Jan 1, 2011·Journal of Central Nervous System Disease·Ginger C MintonBryan L Love
Jun 26, 2013·The Cochrane Database of Systematic Reviews·Mattias LindeDouglas C McCrory
Aug 4, 2018·CNS Drugs·Michael J Marmura, Aliza S Kumpinsky
Feb 17, 2019·The Journal of Headache and Pain·D García-AzorinA L Guerrero-Peral
Mar 25, 2019·Current Treatment Options in Neurology·Arash Danesh, P Christopher H Gottschalk
Mar 19, 2019·Current Treatment Options in Neurology·Simy K Parikh, Stephen D Silberstein
Dec 7, 2019·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Carlo FumagalliDiego Fornasari

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.